Placebo inhalation aerosol

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 3

Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD)

CompletedNCT02173691

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 1999-02-28Updated: 2014-06-26

Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease

CompletedNCT02177253

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2002-10-31Updated: 2014-06-27